Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19854 studies found for:    "Vascular Diseases"
Show Display Options
Rank Status Study
1 Completed Center for the Study of Vascular Disease in Hispanic and Native Americans
Condition: Vascular Disease
Intervention:
2 Completed Beijing Vascular Disease Patients Evaluation STudy
Condition: Vascular Disease
Intervention: Other: Questionnaires and follow-up
3 Recruiting Pulmonary Vascular Disease Phenomics Program PVDOMICS
Condition: Pulmonary Vascular Disease
Intervention: Other: No Intervention
4 Completed Efficacy of Patient Centred Information for Vascular Disease
Condition: Vascular Disease
Interventions: Other: Verbal and written information;   Other: Verbal and electronic information
5 Completed Open Label Clinical Study to Assess the Clinical Safety of a New Compression Device in Subjects With Peripheral Arterial Vascular Disease
Condition: Peripheral Arterial Vascular Disease
Intervention: Procedure: A new treatment approach is to have an effective working pressure combined with a low resting pressure.
6 Completed Screening DIVA - Diffuse Vascular Disease
Condition: Peripheral Vascular Diseases
Intervention:
7 Completed Stem Cell Injection for Peripheral Vascular Disease
Condition: Peripheral Vascular Disease
Intervention: Biological: Stem Cell Transplantation
8 Not yet recruiting Multi-spectral Imaging to Assess Wounds in Peripheral Vascular Disease Patients
Condition: Peripheral Vascular Disease Patient
Intervention: Device: Multi-spectral Imaging Device (MSID)
9 Completed
Has Results
Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
Condition: Vascular Diseases
Interventions: Drug: Gadobutrol (Gadavist, Gadovist, BAY86-4875);   Drug: Gadopentate dimeglumine (Magnevist, BAY86-4882)
10 Completed Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
Conditions: Vascular Disease;   Vascular Disease Risk
Intervention:
11 Unknown  Noninvasive Predictors of Transplant Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention:
12 Completed Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease
Conditions: Hemodialysis Patients;   Peripheral Vascular Disease
Intervention: Drug: Cilostazol
13 Withdrawn Noninvasive Evaluation of Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention:
14 Terminated Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
Condition: Cardiac Allograft Vasculopathy
Intervention: Drug: Sirolimus
15 Unknown  Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: Intravitreal Bevacizumab
16 Active, not recruiting Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
Condition: Cardiac Allograft Vasculopathy
Intervention:
17 Completed Response to Ranibizumab in Polypoidal Choroidal Vasculopathy (PCV)and SNPs
Condition: Polypoidal Choroidal Vasculopathy
Intervention:
18 Completed Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease
Condition: PERIPHERAL VASCULAR DISEASE
Interventions: Procedure: Conventional angioplasty balloon;   Procedure: cryoplasty balloon
19 Completed Testosterone Replacement in Diabetes With Vascular Disease (Version 2)
Conditions: Diabetes Mellitus;   Peripheral Vascular Disease
Interventions: Drug: Testosterone;   Drug: 0.9% saline
20 Active, not recruiting Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling
Conditions: Vasculopathy;   Allograft
Intervention: Procedure: Dobutamine stress echocardiography, coronarography, brachial arterial echography

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.